Pharmaceutical Industry Information Portal

HomeNews

News

Alladapt announces $119M institutional financing to support ongoing clinical development

Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced today the closing of a $119 million...

ResApp stock returned from trading halt, down 29%

The ResApp Health Ltd share price has returned from its trading halt and taken a tumble. In morning trade, the digital health company’s shares...

Mereo BioPharma rises as AstraZeneca reportedly considers buying

Shares of Mereo BioPharma (MREO), a small biotech company focused on developing therapies for cancer and rare diseases surged 62.5% on Jun 17, following...

Merck looks to acquire Seagen

Pharmaceutical giant Merck is exploring a possible purchase of biotech company Seagen, according to The Wall Street Journal. No deal is imminent, sources told the...

Pfizer to buy 8.1% stake in vaccines company Valneva

U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1% percent stake in French vaccines company, as...

Abbott infant formula plant closes again after severe storms and flooding, shares plummet

Abbott Laboratories (ABT.N) has stopped production of the EleCare specialty baby formula at its plant in southwestern Michigan after thunderstorms and heavy rains flooded...
spot_img

Expert Articles

spot_img